372 related articles for article (PubMed ID: 21301796)
1. Inborn and acquired metabolic defects in cancer.
Frezza C; Pollard PJ; Gottlieb E
J Mol Med (Berl); 2011 Mar; 89(3):213-20. PubMed ID: 21301796
[TBL] [Abstract][Full Text] [Related]
2. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
Laurenti G; Tennant DA
Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the TCA cycle: signaling to tumor formation.
Raimundo N; Baysal BE; Shadel GS
Trends Mol Med; 2011 Nov; 17(11):641-9. PubMed ID: 21764377
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
Desideri E; Vegliante R; Ciriolo MR
Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
[TBL] [Abstract][Full Text] [Related]
5. The functional roles of TCA cycle metabolites in cancer.
Eniafe J; Jiang S
Oncogene; 2021 May; 40(19):3351-3363. PubMed ID: 33864000
[TBL] [Abstract][Full Text] [Related]
6. Metabolic alteration in tumorigenesis.
Yang H; Xiong Y; Guan K
Sci China Life Sci; 2013 Dec; 56(12):1067-75. PubMed ID: 24114443
[TBL] [Abstract][Full Text] [Related]
7. The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.
Schaefer IM; Hornick JL; Bovée JVMG
Lab Invest; 2018 Apr; 98(4):414-426. PubMed ID: 29339836
[TBL] [Abstract][Full Text] [Related]
8. Cancer. Puzzling patterns of predisposition.
Pollard PJ; Ratcliffe PJ
Science; 2009 Apr; 324(5924):192-4. PubMed ID: 19359573
[No Abstract] [Full Text] [Related]
9. Mitochondrial metabolic remodeling in response to genetic and environmental perturbations.
Hollinshead KE; Tennant DA
Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):272-85. PubMed ID: 27196610
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer metabolism.
Teicher BA; Linehan WM; Helman LJ
Clin Cancer Res; 2012 Oct; 18(20):5537-45. PubMed ID: 23071355
[TBL] [Abstract][Full Text] [Related]
11. Genetically-defined metabolic reprogramming in cancer.
Mullen AR; DeBerardinis RJ
Trends Endocrinol Metab; 2012 Nov; 23(11):552-9. PubMed ID: 22858391
[TBL] [Abstract][Full Text] [Related]
12. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase.
Pollard PJ; Wortham NC; Tomlinson IP
Ann Med; 2003; 35(8):632-9. PubMed ID: 14708972
[TBL] [Abstract][Full Text] [Related]
13. The role of mutation of metabolism-related genes in genomic hypermethylation.
Waterfall JJ; Killian JK; Meltzer PS
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):16-23. PubMed ID: 25111818
[TBL] [Abstract][Full Text] [Related]
14. Metabolic enzymes as oncogenes or tumor suppressors.
Thompson CB
N Engl J Med; 2009 Feb; 360(8):813-5. PubMed ID: 19228626
[No Abstract] [Full Text] [Related]
15. Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.
Menendez JA; Alarcón T; Joven J
Cell Cycle; 2014; 13(5):699-709. PubMed ID: 24526120
[TBL] [Abstract][Full Text] [Related]
16. Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree?
Bayley JP; Devilee P
Curr Opin Genet Dev; 2010 Jun; 20(3):324-9. PubMed ID: 20304625
[TBL] [Abstract][Full Text] [Related]
17. Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation.
Brière JJ; Favier J; Gimenez-Roqueplo AP; Rustin P
Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1114-20. PubMed ID: 16760265
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations in Krebs cycle and its impact on cancer pathogenesis.
Sajnani K; Islam F; Smith RA; Gopalan V; Lam AK
Biochimie; 2017 Apr; 135():164-172. PubMed ID: 28219702
[TBL] [Abstract][Full Text] [Related]
19. Biochemical assays for mitochondrial activity: assays of TCA cycle enzymes and PDHc.
Reisch AS; Elpeleg O
Methods Cell Biol; 2007; 80():199-222. PubMed ID: 17445696
[No Abstract] [Full Text] [Related]
20. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.
Xiao M; Yang H; Xu W; Ma S; Lin H; Zhu H; Liu L; Liu Y; Yang C; Xu Y; Zhao S; Ye D; Xiong Y; Guan KL
Genes Dev; 2012 Jun; 26(12):1326-38. PubMed ID: 22677546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]